Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials

IMPORTANCE: Intravenous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce fibroblast growth factor 23–mediated hypophosphatemia. OBJECTIVE: To compare risks of hypophosphatemia and effects on biomarkers of mineral and bone homeostasis of intravenous iron isomal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA
Autors principals: Wolf, Myles, Rubin, Janet, Achebe, Maureen, Econs, Michael J., Peacock, Munro, Imel, Erik A., Thomsen, Lars L., Carpenter, Thomas O., Weber, Thomas, Brandenburg, Vincent, Zoller, Heinz
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042864/
https://ncbi.nlm.nih.gov/pubmed/32016310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.22450
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars